| DIRECT COMPETITOR COMPARISON | |
| RELV | HLF | MTEX | NATR | Industry | | Market Cap: | 43.67M | 2.63B | 61.96M | 124.08M | 179.44M | | Employees: | 247 | 4,000 | 540 | 1,183 | 86 | | Qtrly Rev Growth (yoy): | -12.50% | -0.30% | -8.60% | -7.40% | 22.40% | | Revenue (ttm): | 86.83M | 2.21B | 296.12M | 341.31M | 42.63M | | Gross Margin (ttm): | 80.62% | 46.62% | 33.73% | 79.68% | 56.06% | | EBITDA (ttm): | 5.06M | 338.70M | -13.62M | 9.15M | -7.66M | | Oper Margins (ttm): | 4.41% | 12.65% | -8.80% | 1.37% | 2.25% | | Net Income (ttm): | 2.00M | 181.35M | -18.90M | 1.62M | N/A | | EPS (ttm): | 0.149 | 2.862 | -0.714 | 0.105 | -0.17 | | P/E (ttm): | 23.96 | 15.11 | N/A | 76.19 | 18.31 | | PEG (5 yr expected): | 1.04 | 0.99 | N/A | N/A | 1.04 | | P/S (ttm): | 0.51 | 1.20 | 0.22 | 0.36 | 4.43 |
|
| HLF = Herbalife Ltd. | | MTEX = Mannatech Inc. | | NATR = Nature's Sunshine Products Inc. | | Industry = Drug Manufacturers - Other | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 55.93 | -0.97% | 56.61B | 12.20 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.06 | -0.50% | 13.90B | 16.08 | | Genzyme Corp. | GENZ | 49.42 | -0.60% | 13.12B | 28.18 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.12 | -1.07% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.87 | -1.48% | 8.89B | 1017.76 | | Teva Pharmaceutical Industries Limited | TEVA | 52.44 | -1.52% | 46.20B | 47.98 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.77 | -0.42% | 4.01B | 19.47 | | King Pharmaceuticals Inc. | KG | 11.30 | -1.91% | 2.81B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.14 | -0.22% | 5.54B | 111.29 | | Pfizer Inc. | PFE | 17.76 | -1.66% | 143.31B | 14.75 | | Johnson & Johnson | JNJ | 64.25 | -0.19% | 177.27B | 14.03 | | GlaxoSmithKline plc | GSK | 42.05 | -1.38% | 106.60B | 13.26 | | Sanofi-Aventis | SNY | 38.73 | -0.13% | 101.13B | N/A | | Novartis AG | NVS | 55.33 | -0.31% | 125.67B | 16.57 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 40.80 | -1.35% | N/A | N/A | | AstraZeneca plc | AZN | 45.70 | -0.93% | 66.27B | 9.18 | | Abbott Laboratories | ABT | 53.24 | -0.78% | 82.35B | 14.42 | | Bristol-Myers Squibb Co. | BMY | 24.90 | -1.50% | 49.33B | 12.88 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | HLF | | Streetwalker: Five Cash-Rich Companies
Tue 6:00pm -
at Forbes.com | | • | HLF | | Herbalife Ltd. To Participate in Wedbush California Dreamin' Management Access Conference
Tue 1:59pm -
Business Wire | | • | HLF | | Whitney Tilson Gets Defensive
Tue 1:05am -
at Seeking Alpha | | • | HLF | | Herbalife Ltd. (HLF): Zacks Rank Buy
Mon 1:00am -
Zacks.com | | • | MTEX | | MANNATECH INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Fri, Dec 4 -
EDGAR Online | | • | MTEX | | Mannatech CEO steps downs
Fri, Dec 4 -
at bizjournals.com | | • | MTEX | | Mannatech Appoints Company Veterans as co-CEOs
Thu, Dec 3 -
Business Wire | | • | HLF | | Sell-Side Is Complacent in the Face of Dubai
Tue, Dec 1 -
at Seeking Alpha | | • | HLF | | '10 Feels Pretty, Oh So Pretty
Fri, Nov 27 -
Investor's Business Daily | | • | MTEX | | Mannatech's Educational Web Site Receives Web Health Merit Award
Tue, Nov 24 -
Business Wire | | • | HLF | | Five Ways to Avoid (Personal) Excess Baggage When Traveling This Holiday Season
Thu, Nov 19 -
Business Wire | | • | HLF | | Investors Find Fat Gains in Nutrition Stocks
Tue, Nov 17 -
Indie Research | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Thu, Nov 12 -
EDGAR Online | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Mon, Nov 9 -
EDGAR Online | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Files SEC form 10-Q, Quarterly Report
Mon, Nov 9 -
EDGAR Online | | • | NATR | | Nature's Sunshine Products Reports Third Quarter Operating Results
Fri, Nov 6 -
Business Wire | | | All Headlines for these symbols... |
|
|
|
1.00% Nasdaq 
Competitors
